Sagimet Biosciences Inc. Series A Common Stock (SGMT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $728.71M
Last updated: Nov 17, 2026 at 4:18 PM ET
Sagimet Biosciences Inc. Series A Common Stock (SGMT) Stock Chart
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a latest price of $9.85 on Nov 17, 2026, 14.0% below its 52-week high of $11.45. Its price rose 27.1% over the past 12 months. The month-end price rose 171.0% over the 3 years through Oct 2026, a compound annual rate of 39.4%.
Price Chart
From Jul 2023 to Oct 2026, its highest month-end close was $15.95 in Jul 2023 and its lowest $2.77 in Sep 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SGMT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SGMT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 6.9%, and over 6 months it rose 50.6%.
| Period | Change |
|---|---|
| 1 month | +11.2% |
| 3 months | -6.9% |
| 6 months | +50.6% |
| 12 months | +27.1% |
| 12 months, with dividends | +27.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +171.0% | +39.4% |
Price by Year
Its best calendar year was 2025, when the price rose 31.6%, and its weakest was 2024, when it fell 17.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.92 | +67.6% |
| 2025 | $5.92 | +31.6% |
| 2024 | $4.50 | -17.0% |
Trading Range
The price is at its 50-day average of $9.85 and 27.1% above its 200-day average of $7.75.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $9.85 | |
| 52-week high | $11.45 | -14.0% |
| 52-week low | $4.50 | +118.9% |
| 50-day average | $9.85 | 0.0% |
| 200-day average | $7.75 | +27.1% |
Price Risk
Over 3 years, its largest fall from a peak was 89.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.88 |
| Largest fall, 1 year | -42.0% |
| Largest fall, 3 years | -89.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SGMT
What is SGMT's 1-year price change?
Sagimet Biosciences Inc. Series A Common Stock's price rose 27.1% over the past 12 months. With dividends included, the 12-month total return was 27.1%.
How has SGMT stock done over the long term?
Sagimet Biosciences Inc. Series A Common Stock's month-end price rose 171.0% over the 3 years through Oct 2026, a compound annual rate of 39.4%. These figures leave out dividends.
What is SGMT's 52-week high and low?
Sagimet Biosciences Inc. Series A Common Stock's 52-week high is $11.45 and its 52-week low is $4.50. Its latest price of $9.85 on Nov 17, 2026 is 14.0% below the high.
What is SGMT's beta?
Sagimet Biosciences Inc. Series A Common Stock's 1-year beta against the S&P 500 is 1.88, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 42.0%.
Is the SGMT chart free?
Yes. Advanced Charting for SGMT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SGMT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors